Frequency of rearrangements in Lynch syndrome cases associated with MSH2: Characterization of a new deletion involving both EPCAM and the 5′ part of MSH2

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1556-1562

  Pérez Cabornero, Lucia ^a   Infante Sanz, Mar ^a   Velasco Sampedro, Eladio ^a   Lastra Aras, Enrique ^b   Acedo Becares, Alberto ^a   Miner Pino, Cristina ^a   Durań Domińguez, Mercedes ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MSH2;

ADULT; ARTICLE; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOSS; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL ADHESION MOLECULES; CHROMOSOME BREAKPOINTS; COHORT STUDIES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE REARRANGEMENT; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTS HOMOLOG 2 PROTEIN; PEDIGREE; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 80053906149     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0080     Document Type: Article

References (19)

1. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1994;77:1.
2. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 1994;368:258-61.
3. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, RubenSM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80. (Pubitemid 24277467)
4. Wijnen J, van der KH, Vasen H, Khan PM, Menko F, Tops C, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998;20:326-8.
5. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009;76:1-18.
6. Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001;10:735-40. (Pubitemid 32331582)
7. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
8. Hastings PJ, Lupski JR, Rosenberg SM, Ira G. Mechanisms of change in gene copy number. Nat Rev Genet 2009;10:551-64.
9. Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 30 exons of TACSTD1. Nat Genet 2009;41:112-7.
10. Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 2009;30:197-203.
11. Guarinos C, Castillejo A, Barbera VM, Perez-Carbonell L, Sanchez-Heras AB, Segura A, et al. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients. J Mol Diagn 2010;12:765-70.
12. Nagasaka T, Rhees J, Kloor M, Gebert J, Naomoto Y, Boland CR, et al. Somatic hypermethylation of MSH2 is a frequent event in Lynch syndrome colorectal cancers. Cancer Res 2010;70:3098-108.
13. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 2011;12:49-55.
14. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57. (Pubitemid 28521189)
15. Velasco E, Infante M, Duran M, Esteban-Cardenosa E, Lastra E, Garcia-Giron C, et al. Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis. Electrophoresis 2005;26:2539-52. (Pubitemid 40990600)
16. Perez-Cabornero L, Velasco E, Infante M, Sanz D, Lastra E, Hernandez L, et al. A new strategy to screen MMR genes in Lynch syndrome: HA-CAE, MLPA, and RT-PCR. Eur J Cancer 2009;45:1485-93.
17. Pistorius S, Gorgens H, Plaschke J, Hoehl R, Kruger S, Engel C, et al. Genomic rearrangements in MSH2, MLH1, or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 2007;248:89-95.
18. Castellvi-Bel S, Castells A, Strunk M, Ferrandez A, Piazuelo E, Mila MP, et al. Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett 2005;225:93-98. (Pubitemid 40732772)
19. Martinez-Bouzas C, Ojembarrena E, Beristain E, Errasti J, Viguera N, Tejada Minguez MI. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett 2007;255:295-9. (Pubitemid 47268646)